Momentum Bioscience

United Kingdom
Reading, England, United Kingdom, RG6 6BZ

Company profile

Momentum Bioscience company profile

Momentum Bioscience Ltd has a novel and innovative approach for the detection of infection in blood and other normally sterile body fluids. There Enzyme Mediated Amplification technology allows universal detection of viable bacteria and fungi in <2 hours vs 1-5 days with current laboratory techniques. It is the only rapid technology available that specifically measures viable organisms Momentum Bioscience Ltd is developing a suite of related technologies collectively termed Enzyme Mediated Amplification (EMA), for the rapid detection of pathogens found in blood and normally sterile fluids (NSF).

Business identity

Contact email
[email protected]
Phone number
44 1189 357 344
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2005-01-01, Year

Headquarters

Postal code
RG6 6BZ
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$3.9M
Last funding
Series B / 2015-07-17
Last equity funding
Series B
Investors
4
Lead investors
1
Founders
2
Articles
6

Founders and investors

Founders

Bill MullenJim Heath

Lead investors

The FSE Group

Investors

London Business Angels (LBA)Longwall VentureThe FSE GroupWren Capital